Cardiovascular and Renal Outcomes With Telmisartan, Ramipril, or Both in People at High Renal Risk: Results From the ONTARGET and TRANSCEND Studies -- Tobe et al., 10.1161/CIRCULATIONAHA.110.964171 -- Circulation
Links shared publicly online about this topic.
- 471total visits
Cardiovascular and Renal Outcomes With Telmisartan, Ramipril, or Both in People at High Renal Risk: Results From the ONTARGET and TRANSCEND Studies -- Tobe et al., 10.1161/CIRCULATIONAHA.110.964171 -- Circulation
Cardiovascular and Renal Outcomes With Telmisartan, Ramipril, or Both in People at High Renal Risk: Results From the ONTARGET and TRANSCEND Studies -- Tobe et al., 10.1161/CIRCULATIONAHA.110.964171 -- Circulation
View full resource at circ.ahajournals.org
Tags: Post Heart Attack Medication, Heart Failure Medication, High Blood Pressure Medication, Kidney Health, Urinary System, Micardis, Delix, Tritace
Most Recently Shared on March 1, 2011 at 4:00 pm By:
http://bit.ly/frxYdt CV& Renal Outcomes With Telmisartan & or Ramipril in High Renal Risk:From ONTARGET& TRANSCEND-no benefit of dual Rx
Advertisement
